Close

Needham & Company Upgrades OncoGenex Pharmaceuticals (OGXI) to Strong Buy

October 28, 2013 7:43 AM EDT Send to a Friend
Needham & Company upgraded OncoGenex Pharmaceuticals (NASDAQ: OGXI) from Buy to Strong Buy with a price target of $30.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login